CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated With Darolutamide or Enzalutamide (ARACOG)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04335682
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-22T00:07:37.498806+00:00
Published At: 2026-09-21T00:00:00+00:00
Record Updated At: 2026-09-21
Results Posted At: 2026-09-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Prostate Cancer", "Prostate Cancer Metastatic", "Prostate Cancer", "Castrate Resistant Prostate Cancer", "Hormone Sensitive Prostate Cancer", "Non-metastatic Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-21"
protocolSection.identificationModule.nctId: "NCT04335682"
protocolSection.identificationModule.officialTitle: "A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated With Darolutamide or Enzalutamide (ARACOG)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-09-21"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.